Effectiveness and Safety of PD-1 Inhibitor Monotherapy for Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Exploratory Study

<div>CT scan results of the changes for target lesions in the lung site of a female patient (PR) with advanced NSCLC before (a) and after the administration of sintilimab (b).</div>

Journal of Oncology

fig3

Figure 3

Figure 3: Effectiveness and Safety of PD-1 Inhibitor Monotherapy for Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Exploratory Study 

Figure 3 | Effectiveness and Safety of PD-1 Inhibitor Monotherapy for Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Exploratory Study 